0001144204-12-020459.txt : 20120405
0001144204-12-020459.hdr.sgml : 20120405
20120405200142
ACCESSION NUMBER: 0001144204-12-020459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120405
FILED AS OF DATE: 20120405
DATE AS OF CHANGE: 20120405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliviero James F III
CENTRAL INDEX KEY: 0001434718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 12746896
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
v308674_4.xml
OWNERSHIP DOCUMENT
X0305
4
2012-04-05
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001434718
Oliviero James F III
C/O KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
0
1
0
0
Chief Financial Officer
Common Stock
2012-04-05
4
S
0
5458
1.601
D
176560
D
Sale of a total of 5,458 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on April 2, 2012. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Of the 176,560 shares, 71,853 are shares of restricted stock.
/s/ James F. Oliviero, III
2012-04-05